Cytosorbents Corporation (CTSO) vs Dare Bioscience, Inc. (DARE)
A side-by-side comparison of Cytosorbents Corporation and Dare Bioscience, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CTSO
Cytosorbents Corporation
$3.96HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
DARE
Dare Bioscience, Inc.
$0.83HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — CTSO vs DARE
growth of $100 · dividends reinvested · last 10yCTSO -97.1% (-29.7%/yr)DARE -99.3% (-39.1%/yr)CTSO compounded faster over this window
CTSO DARE
CTSO vs DARE: by the numbers
- •DARE is the larger company ($12M vs $12M market cap).
- •Both run net losses; CTSO's is the smaller (-48.94% vs -804.37% net margin).
Metrics side by side
Valuation
| Metric | CTSO | DARE |
|---|---|---|
| P/S ratio | 0.33 | 9.14 |
Profitability
| Metric | CTSO | DARE |
|---|---|---|
| Gross margin | 71.61% | -137.55% |
| Operating margin | -33.37% | -1315.51% |
| Net margin | -48.94% | -804.37% |
| ROIC | -43.31% | -203.50% |
Growth (annualized)
| Metric | CTSO | DARE |
|---|---|---|
| Revenue CAGR (5Y) | -3.17% | N/A |
| Total return CAGR (5Y) | -52.26% | -46.35% |
Frequently asked
- How have CTSO and DARE total returns compared?
- Over the past 10 years, CTSO delivered -28.72% and DARE delivered -39.10% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.